Bionexo founder’s psychological well being healthtech has simply raised the seed
In March, businessman Mauricio Barbosa, founder of healthtech Bionexo, exclusively revealed to the NeoFeed that he was creating a new company, focused on mental health treatment, and that he would start raising funds to get the project up and running. Well, he just finished the round.
The new healthtech, called Elibré, raised R$7 million with investors such as João Ayres Rabello Filho, a veteran of the financial sector who presided over some banks; Marcelo Hallack, from Prisma Capital; Francisco Guimarães, from the Pinheiro Guimarães law firm; and Apus Capital, from Barbosa, among others.
Healthtech was born with a boutique hospital with 16 apartments and will open its doors in December. “It is the peak period of psychiatric hospitalizations due to the end-of-the-year festivities”, says Barbosa to the NeoFeed. Elibré will be located in Granja Viana, in São Paulo, and will occupy a space of 1 thousand square meters in a hospital belonging to the São Camilo Group.
The daily rates have not yet been defined, but it will not serve the SUS and health plans: only private customers. The technological platform will come into action from the moment patients are discharged. “Usually, this type of patient stays between 14 and 21 days in hospital”, says Barbosa.
Barbosa says that the platform will have full-time psychiatry, specialized nursing and psychologists. The CEO hired is Henrique Paiva, a psychiatrist specializing in Unicamp and USP. And, in this first stage, the project will focus on patients suffering from the so-called mood disorders, facing depression and suicide and dependent on alcohol and drugs.
“This will be our first Elibré. We want to spread units throughout Brazil and South America”, says Barbosa. In addition to the physical units, the idea is to sell the patient monitoring technology platform as a SaaS to other hospitals. As he has connections with almost all hospitals in the country through Bionexo, Barbosa already starts with an advantage.
The businessman decided to study this market after he himself went through depression and discovered that, if he needed to be hospitalized, he would have to share a room with six other people – each with a different problem – with a psychiatrist’s visit on just one day a week.
It was there that a group of professors and doctors from Unicamp, in Campinas (SP), such as Carlos Cais, Lucas Mella, Renata Azevedo and Tânia Vichi, sought out a group to understand how they could create a business and differentiate themselves in the market. The thesis and the speech are good, but this will only be, in fact, proven when it is on the air.